youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
NTRA:NASDAQ
Natera Inc
$378.92
arrow_downward
-8.54%(-35.38) 1D
$377.22
arrow_downward
-0.45% (-1.70)bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$418.41
High
$418.41
Low
$376.38
Mkt. cap
54.62B
Avg. vol.
1.66M
Volume
2.63M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$418.41
High
$418.41
Low
$376.38
Mkt. cap
54.62B
Avg. vol.
1.66M
Volume
2.63M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
GuruFocus
·
2 days ago
Natera (NTRA) CFO Michael Brophy Sells 3,084 Shares as Stock Tra
Investing.com
·
3 days ago
Natera CFO Michael Brophy sells $1.31 million in common stock
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com